|
|
||||||||
Ann Thorac Surg 1998;66:1658-1661
© 1998 The Society of Thoracic Surgeons
a Division of Cardiovascular Diseases, Department of Medicine, Mayo Clinic and Foundation, Rochester, Minnesota, USA
Accepted for publication May 22, 1998.
Address reprint requests to Dr Terzic, Division of Cardiovascular Diseases, Department of Medicine, Guggenheim-7F, Mayo Clinic and Foundation, Rochester, MN 55905
Background. Hyperkalemic cardioplegic solutions effectively arrest the heart, but may also induce intracellular Ca2+ loading and cellular hypercontracture, which could contribute to ventricular dysfunction associated with global surgical ischemia. Recently, it has been proposed that 17ß-estradiol may possess protective properties in the ischemic myocardium. The purpose of the present study was to examine the action of 17ß-estradiol on cardiac cells exposed to hyperkalemic stress.
Methods. Single ventricular cardiomyocytes, a preparation devoid of vascular and neuronal elements, were isolated from guinea pig hearts, loaded with a Ca2+-sensitive fluorescent probe, and imaged by digital epifluorescent microscopy. The emitted fluorescence of the probe, a measure of intracellular Ca2+ concentration, and cell length were simultaneously recorded during hyperkalemic challenge, in the absence or presence of 17ß-estradiol.
Results. In control cardiomyocytes, the cytosolic concentration of Ca2+ was 138 ± 11 nmol/L and cell length 93 ± 11 µm. Exposure to high K+ (+16 mmol/L KCl) significantly increased cytosolic Ca2+ to 2,191 ± 187 nmol/L (p < 0.001), and produced cell shortening (length at 39 ± 5 µm; p < 0.001). 17ß-Estradiol (10 µmol/L) acutely prevented high K+ to induce either intracellular Ca2+ loading (144 ± 13 nmol/L, p < 0.001) or hypercontracture (91 ± 10 µm, p < 0.001). Tamoxifen (10 µmol/L), an antiestrogen, abolished the protective effect of 17ß-estradiol.
Conclusions. We conclude that 17ß-estradiol prevents hyperkalemia-induced Ca2+ loading and hypercontracture through a direct and tamoxifen-sensitive action in cardiomyocytes. This study raises the possibility that 17ß-estradiol should be considered as a cardioprotective adjunct toward a safer hyperkalemic cardioplegia.
This article has been cited by other articles:
![]() |
Q. Yang and G.-W. He Effect of Cardioplegic and Organ Preservation Solutions and Their Components on Coronary Endothelium-Derived Relaxing Factors Ann. Thorac. Surg., August 1, 2005; 80(2): 757 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mukherjee, W. M. Yarbrough, E. S. Reese, J. S. Leiser, J. A. Sample, J. T. Mingoia, A. E. Hardin, R. E. Stroud, J. E. McLean, J. W. Hendrick, et al. Myocyte contractility with caspase inhibition and simulated hyperkalemic cardioplegic arrest Ann. Thorac. Surg., May 1, 2004; 77(5): 1684 - 1689. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zhai, T. E. Eurell, R. P. Cotthaus, E. H. Jeffery, J. M. Bahr, and D. R. Gross Effects of dietary phytoestrogen on global myocardial ischemia-reperfusion injury in isolated female rat hearts Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1223 - H1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Rouleau, A. Dagnault, D. Simard, B. Lavallee, A. Belanger, A. Blouin, and J. G. Kingma Jr. Effect of estrogen replacement therapy on distribution of myocardial blood flow in female anesthetized rabbits Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1407 - H1412. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Zhai, T. E. Eurell, R. Cotthaus, E. H. Jeffery, J. M. Bahr, and D. R. Gross Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2766 - H2775. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |